VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹584 Cr | ₹542 Cr | ₹495 Cr | ₹538 Cr | ₹494 Cr |
What is the latest Total Expenditure of VENUS REMEDIES ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹584 Cr |
| Mar2024 | ₹542 Cr |
| Mar2023 | ₹495 Cr |
| Mar2022 | ₹538 Cr |
| Mar2021 | ₹494 Cr |
How is Total Expenditure of VENUS REMEDIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹584 Cr | 7.84 | |
| Mar2024 | ₹542 Cr | 9.36 | |
| Mar2023 | ₹495 Cr | -7.91 | |
| Mar2022 | ₹538 Cr | 8.84 | |
| Mar2021 | ₹494 Cr | - | |
Compare Total Expenditure of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,607.5 Cr | 10.6% | 67.2% | 334.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 10.6% |
67.2% |
334.2% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses